Enfuvirtide for prophylaxis against HIV infection

N Engl J Med. 2003 Nov 27;349(22):2169-70; author reply 2169-70. doi: 10.1056/NEJM200311273492218.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Drug Resistance
  • Enfuvirtide
  • HIV Envelope Protein gp41 / economics
  • HIV Envelope Protein gp41 / therapeutic use*
  • HIV Fusion Inhibitors / economics
  • HIV Fusion Inhibitors / therapeutic use*
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • HIV-1*
  • Humans
  • Peptide Fragments / economics
  • Peptide Fragments / therapeutic use*

Substances

  • HIV Envelope Protein gp41
  • HIV Fusion Inhibitors
  • Peptide Fragments
  • Enfuvirtide